These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25521974)

  • 41. [Statement of conscience in trisomy 21 screening: pregnant women's free will jeopardized].
    Azria E
    J Gynecol Obstet Biol Reprod (Paris); 2010 Nov; 39(7):592-4. PubMed ID: 20926207
    [No Abstract]   [Full Text] [Related]  

  • 42. The ethics of abortions for fetuses with congenital abnormalities.
    Jotkowitz A; Zivotofsky AZ
    Eur J Obstet Gynecol Reprod Biol; 2010 Oct; 152(2):148-51. PubMed ID: 20561739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of spina bifida--the parents' choice.
    Nature; 1978 Feb; 271(5646):595. PubMed ID: 11643438
    [No Abstract]   [Full Text] [Related]  

  • 44. In new tests for fetal defects, agonizing choices for parents.
    Harmon A
    N Y Times Web; 2004 Jun; ():A1, A19. PubMed ID: 15218880
    [No Abstract]   [Full Text] [Related]  

  • 45. [Is informed consent actually possible?].
    Rehmann-Sutter C
    Ther Umsch; 2006 Nov; 63(11):699-702. PubMed ID: 17075784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.
    Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
    AJOB Empir Bioeth; 2018; 9(2):99-111. PubMed ID: 29847254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disability advocacy and reproductive choice: engaging with the expressivist objection.
    Peterson M
    J Genet Couns; 2012 Feb; 21(1):13-6. PubMed ID: 22037896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How
    Kittay EF
    Kennedy Inst Ethics J; 2017; 27(2):185-215. PubMed ID: 28736419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Qualifying choice: ethical reflection on the scope of prenatal screening.
    Stapleton G
    Med Health Care Philos; 2017 Jun; 20(2):195-205. PubMed ID: 27631408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The triple screen in prenatal care: not just a simple blood test.
    Wagner AF; Wagner AM
    Trends Health Care Law Ethics; 1994; 9(3):33-8. PubMed ID: 11652975
    [No Abstract]   [Full Text] [Related]  

  • 51. Informed consent or institutionalized eugenics? How the medical profession encourages abortion of fetuses with Down syndrome.
    Dixon DP
    Issues Law Med; 2008; 24(1):3-59. PubMed ID: 18771038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal testing, reproductive autonomy, and disability interests.
    Scott R
    Camb Q Healthc Ethics; 2005; 14(1):65-82. PubMed ID: 15747484
    [No Abstract]   [Full Text] [Related]  

  • 53. [Down syndrome screening: from medical criticism to crisis of conscience].
    Leblanc P; Arduin PO
    J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):509-13. PubMed ID: 20692772
    [No Abstract]   [Full Text] [Related]  

  • 54. Ethical issues related to screening for preeclampsia.
    Jørgensen JM; Hedley PL; Gjerris M; Christiansen M
    Bioethics; 2014 Sep; 28(7):360-7. PubMed ID: 22994561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The problem with an almost-perfect genetic world.
    Harmon A
    N Y Times Web; 2005 Nov; ():WK1, WK14. PubMed ID: 16342438
    [No Abstract]   [Full Text] [Related]  

  • 56. Selective terminations and respect for the disabled.
    Stangl R
    J Med Philos; 2010 Feb; 35(1):32-45. PubMed ID: 20034993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproductive freedom, self-regulation, and the government of impairment in utero.
    Tremain S
    Hypatia; 2006; 21(1):35-53. PubMed ID: 17111555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioethics and the law--the impact of genetic technology on prenatal management.
    McGivern B
    E Law; 1995 Dec; 2(3):E9. PubMed ID: 16969924
    [No Abstract]   [Full Text] [Related]  

  • 59. [Ethical aspects of disclosing information on prenatal screening for Down's syndrome].
    Tóth A; Szabó J
    Orv Hetil; 2005 Feb; 146(6):259-65. PubMed ID: 15779814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of attitudes towards the targets of behaviour in predicting and informing prenatal testing choices.
    Bryant LD; Green JM; Hewison J
    Psychol Health; 2010 Dec; 25(10):1175-94. PubMed ID: 20204949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.